| 中文名 | 非西他滨 |
|---|---|
| 英文名 | 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
| 中文别名 |
5-碘-2'-脱氧-2'-氟-BETA-D-阿糖胞苷
5-碘-2'-脱氧-2'-氟-BETA-D-阿糖胞苷,非西他滨 非西他滨|||FOAC|||FIAC|||NSC 非西他滨,10 MM DMSO 溶液 4-氨基-1-[(2R,3S,4R,5R)-3-氟-4-羟基-5-(羟甲基)氧杂环戊-2-基]-5 4-氨基-1-[(2R,3S,4R,5R)-3-氟-4-羟基-5-(羟甲基)氧杂环戊-2-基]-5-碘嘧啶-2-酮 4-氨基-1-(2-脱氧-2-氟-β-D-阿糖胞苷)-5-碘-2(1H)-嘧啶酮 4-氨基-1-((2R,3S,4R,5R)-3-氟-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮 5-IODO-2'-DEOXY-2'-FLUORO-BETA-D-ABINOCYTIDINE, FIACITABINE,FICA, 非西他滨,ANTIINFECTIVE THERAPY, PHASE II ANTIVIRAL DRUG |
| 英文别名 |
5-Iodo-2’-deoxy-2’-fluoro-beta-D-abinocytidine, Fiacitabine
4-Amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one Fiacitabine,NSC-382097,NSC382097,Herpes simplex virus,HSV,inhibit,Inhibitor 2'-Fluoro-5-iodo-1-b-D-arabinofuranosylcytosine 4-amino-1-(2-deoxy-2-fluoro-b-D-abinofuranosyl)-5-iodo FIAC FICA, NSC382097, FOAC 5-Iodo-2’-deoxy-2’-fluoro-beta-D-abino cytidine 2'-Fluoro-5-iodo-aracytosine NSC382097 FOAC|||FIAC|||NSC 4-Amino-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo-2(1H)-pyrimidinone 4-Amino-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodopyrimidin-2(1H)-one Fluoroiodoaracytidine NSC 382097; FIAC; FOAC;NSC382097; NSC -82097 1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)-5-iodocytosine 4-Amino-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-5-iodo-2(1H)-pyrimidinone 1-(2-Deoxy-2-fluoro-beta-D-abinofuranosyl)-5-iodocytosine NSC-382097;FIAC 2'-fluoro-5-iodoarabinosylcytosine Fluorviodoaracytidine 5-Iodo-2'-deoxy-2'-fluoro-beta-D-abinocytidine 5-Iodo-2’-deoxy-2’-fluoro-β-D-abinocytidine DRG-0077 NSC -82097 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-β-D-abinofuranosyl)-5-iodo 1-(2-Deoxy-2-fluoro-β-D-abinofuranosyl)-5-iodocytosine Fiacitabine (NSC-382097 Fiacitabine, 10 mM in DMSO 4-Amino-1-(2-deoxy-2-fluor-β-D-arabinofuranosyl)-5-iodpyrimidin-2(1H)-on |
| 描述 | Fiacitabine(NSC 382097; FIAC; FOAC)是选择性HSV DNA复制抑制剂,对HSV1和HSV2的IC50分别为2.5 nM和12.6 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 2.4±0.1 g/cm3 |
|---|---|
| 沸点 | 524.6±60.0 °C at 760 mmHg |
| 分子式 | C9H11FIN3O4 |
| 分子量 | 371.104 |
| 闪点 | 271.1±32.9 °C |
| 精确质量 | 370.977814 |
| PSA | 110.60000 |
| LogP | -0.27 |
| 蒸汽压 | 0.0±3.1 mmHg at 25°C |
| 折射率 | 1.791 |
| 储存条件 | 2-8℃ |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:3 3.氢键受体数量:5 4.可旋转化学键数量:2 5.互变异构体数量:3 6.拓扑分子极性表面积:108 7.重原子数量:18 8.表面电荷:0 9.复杂度:430 10.同位素原子数量:0 11.确定原子立构中心数量:4 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
|
~%
69123-90-6 |
| 文献:Tetrahedron, , vol. 68, # 26 p. 5145 - 5151 |
|
~%
69123-90-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 26, # 2 p. 152 - 156 |
|
~%
69123-90-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 26, # 2 p. 152 - 156 |
|
~%
69123-90-6 |
| 文献:Tetrahedron, , vol. 68, # 26 p. 5145 - 5151 |
|
~%
69123-90-6 |
| 文献:Tetrahedron, , vol. 68, # 26 p. 5145 - 5151 |
|
~%
69123-90-6 |
| 文献:Tetrahedron, , vol. 68, # 26 p. 5145 - 5151 |
|
~%
69123-90-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 26, # 2 p. 152 - 156 |
| 上游产品 7 | |
|---|---|
| 下游产品 3 | |